Skip to main content
Log in

Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines

  • Laboratory Investigation
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The hypoxia-inducible enzyme carbonic anhydrase IX (CA IX) has recently been discussed as a surrogate marker of tumor hypoxia, an indicator of prognosis and a potential therapeutic target in malignant glioma. To characterize patterns of expression of CA IX in human malignant glioma cells, we studied CA IX protein, CA9 mRNA and hypoxia-inducible factor-1α (HIF-1α) protein levels in U87-MG, U251, U373 and GaMG cells exposed to in vitro hypoxia (1, 6 or 24 h at 5%, 1% or 0.1% O2). All cell lines displayed a strong hypoxic induction of CA9 mRNA in response to prolonged severe hypoxia with cell-line specific patterns at moderate to mild hypoxia and shorter treatment times. Only U87-MG exhibited a strong constitutive, normoxic expression of CA IX protein without a detectable change under hypoxia. In U251 and GaMG cell lines, a marked induction of CA IX protein in response to severe hypoxia was seen. CA IX changes under severe hypoxia and the inhibitory effect of the glycolysis inhibitor iodoacetate (IAA, 50 µM) on hypoxic CA IX overexpression were paralleled by the results for HIF-1α protein. Therefore, immunohistochemical CA IX staining in human malignant glioma specimens can result from low oxygen concentrations or constitutive, oncogene-related, overexpression both of which may be prognostically relevant.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509–4515

    PubMed  Google Scholar 

  2. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz L, Dewhirst MW (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941–943

    PubMed  CAS  Google Scholar 

  3. Huang LE, Arany Z, Livingston DM, Bunn HF (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 271:32253–32259

    Article  PubMed  CAS  Google Scholar 

  4. Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L (1997) Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 94:5667–5672

    Article  PubMed  CAS  Google Scholar 

  5. Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:1137–1343

    Article  Google Scholar 

  6. Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavskky R, Zatovicova M, Liao S, Portetelle D, Stanbridge EJ, Zavada J, Burny A, Kettmann R (1994) Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9:2788–2888

    Google Scholar 

  7. Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelník V (1993) Expression of MaTu–MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268–274

    PubMed  CAS  Google Scholar 

  8. Pastorekova S, Zavada J (2004) Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther 2:245–262

    Google Scholar 

  9. Hilvo M, Rafajova M, Pastorekova S, Pastorek J, Parkkila S (2004) Expression of carbonic anhydrase IX in mouse tissues. J Histochem Cytochem 52:1313–1322

    Article  PubMed  CAS  Google Scholar 

  10. Ivanov S, Liao SY, Ivanova A, Danilkovich-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905–919

    PubMed  CAS  Google Scholar 

  11. Collingridge DR, Piepmaier JM, Rockwell S, Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53:127–131

    Article  PubMed  CAS  Google Scholar 

  12. Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177–8184

    Article  PubMed  CAS  Google Scholar 

  13. Vordermark D (2005) Significance of hypoxia in malignant glioma. Re: Evans et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177–8184; Clin Cancer Res 11:3966–3967

    Google Scholar 

  14. Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, Ivanov S, Oldfield EH, Brawanski A, Merrill MJ (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncol 7:465–475

    Article  PubMed  CAS  Google Scholar 

  15. Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastorekova S, Pastorek J, Parkkila SM, Haapsalo HK (2006) Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12:473–477

    Article  PubMed  CAS  Google Scholar 

  16. Akslen LA, Andersen KJ, Bjerkvig R (1988) Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8:797–803

    PubMed  CAS  Google Scholar 

  17. Vordermark D, Katzer A, Baier K, Kraft P, Flentje M (2004) Cell-type-specific association of hypoxia-inducible factor-1alpha (HIF-1alpha) protein accumulation and radiobiologic tumor hypoxia. Int J Radiat Oncol Biol Phys 58:1242–1250

    PubMed  CAS  Google Scholar 

  18. Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M (2005) Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61:1197–1207

    Article  PubMed  CAS  Google Scholar 

  19. Chomczynski P, Sacchi V (1987) Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

    Article  PubMed  CAS  Google Scholar 

  20. Said HM, Katzer A, Flentje M, Vordermark D (2005) Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76:200–205

    Article  PubMed  CAS  Google Scholar 

  21. Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47

    Article  PubMed  CAS  Google Scholar 

  22. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732

    Article  PubMed  CAS  Google Scholar 

  23. Wykoff C, Beasley N, Watson P, Turner L, Pastorek J, Wilson G, Turley H, Maxwell P, Pugh C, Ratcliffe P, Harris A (2000) Hypoxia-inducible regulation of tumor-associated carbonic anhydrases. Cancer Res 60:7075–7083

    PubMed  CAS  Google Scholar 

  24. Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61:8924–8929

    PubMed  CAS  Google Scholar 

  25. Svastová E, Hulíková A, Rafajová M, Zatovicová M, Gibadulinová A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastoreková S (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577:439–445

    Article  PubMed  CAS  Google Scholar 

  26. Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A, Aoki H, Kondo Y, Kondo S (2005) Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther 16:685–698

    Article  PubMed  CAS  Google Scholar 

  27. Posch MG, Zang C, Mueller W, Lass U, von Deimling A, Elstner E (2004) Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells. Med Sci Monit 10:BR250–BR254

    PubMed  CAS  Google Scholar 

  28. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954

    Article  PubMed  CAS  Google Scholar 

  29. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469–479

    Article  PubMed  CAS  Google Scholar 

  30. Shinoura N, Sakurai S, Shibasaki F, Asai A, Kirino T, Hamada H (2002) Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas. Br J Cancer 86:587–595

    Article  PubMed  CAS  Google Scholar 

  31. Kaluzova M, Pastorekova S, Pastorek J, Kaluz S (2000) p53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells. Biochim Biophys Acta 1491:20–26

    PubMed  CAS  Google Scholar 

  32. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311–1333

    Article  PubMed  CAS  Google Scholar 

  33. Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG (2004) Genetic and hypoxic regulation of angiogenesis in gliomas. J Neuro-oncol 70:229–243

    Article  Google Scholar 

  34. Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI (1998) Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95:12596–12601

    Article  PubMed  CAS  Google Scholar 

  35. Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311

    Article  PubMed  CAS  Google Scholar 

  36. Prendergast GC, Cole MD (1989) Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol 9:124–134

    PubMed  CAS  Google Scholar 

  37. Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24:727–735

    Article  PubMed  CAS  Google Scholar 

  38. Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9:802–811

    PubMed  CAS  Google Scholar 

  39. Parkkila S, Rajaniemi H, Parkkila AK, Kivelä J, Waheed A, Pastoreková S, Pastorek J, Sly WS (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 5:2220–2224

    Article  Google Scholar 

  40. Chrastina A, Pastorekova S, Pastorek J (2003) Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. Neoplasma 50:13–21

    PubMed  CAS  Google Scholar 

  41. Semenza GL, Roth PH, Fang H-M, Wang LW (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757–23763

    PubMed  CAS  Google Scholar 

  42. Holbrook JJ, Liljas A, Steindel SJ, Rossman MG (1975), Lactate dehydrogenase. In: Boyer PD (eds) The enzymes. Volume 11, 3rd ed. Academic Press, NY, pp 191–292

    Google Scholar 

  43. Harris RA, Bowker-Kinley MM, Hyang B, Wu P (2002) Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul 42:249–259

    Article  PubMed  CAS  Google Scholar 

  44. Schmaltz C, Hardenbergh PH, Wells A, Fisher DE (1998) Regulation of proliferation—survival decisions during tumor cell hypoxia. Mol Cell Biol 18:2845–2854

    PubMed  CAS  Google Scholar 

  45. Vordermark D, Kraft P, Katzer A, Bolling T, Willner J, Flentje M (2005) Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett 230:122–133

    Article  PubMed  CAS  Google Scholar 

  46. Staab , Löffler J, Katzer A, Beyer M, Said HM, Polat B, Einsele H, Flentje M, Vordermark D, Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α) (submitted)

Download references

Acknowledgements

This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (to DV) and by IZKF Wuerzburg (to CH and GHV). We thank Prof. Dr. Ulf Rapp, MSZ Institute, University of Würzburg, for the possibility to use the radioactivity laboratories and Bayer Healthcare Co. for provision of the M75 monoclonal antibody.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harun M. Said.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Said, H.M., Staab, A., Hagemann, C. et al. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J Neurooncol 81, 27–38 (2007). https://doi.org/10.1007/s11060-006-9205-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-006-9205-2

Keywords

Navigation